U.S. FDA delays decision on Juul e-cigarettes
A woman holds a Juul e-cigarette in this posed picture, near Jerusalem September 16, 2018. REUTERS/Ronen Zvulun
(Reuters) - The U.S. Food and Drug Administration said on Thursday it needs more time to decide whether e-cigarette maker Juul Labs Inc and other major manufacturers can sell their products in the United States.
The agency had been expected to make a decision by Thursday, a year after Juul and other e-cigarette brands, including British American Tobacco Plc's Vuse and Imperial Brands Plc's Blu, faced a deadline to file applications showing their products provided a net benefit to public health.
The agency said on Thursday that it continues to "work expeditiously on the remaining applications," adding many are "in the final stages of review."
(Reporting by Ankur Banerjee in Bengaluru and Chris Kirkham in Los Angeles; Editing by Shailesh Kuber)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nektar presents early biomarker data for eczema drug at EADV 2026
- AbbVie presents 60 dermatology abstracts at 2026 EADV Congress
- Eupraxia reports 52-week EP-104GI data in esophageal disease trial
Create E-mail Alert Related Categories
FDA, General News, ReutersRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share